Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2025 May 3;25(1):59.
doi: 10.1186/s40644-025-00875-z.

Preoperative prediction of WHO/ISUP grade of ccRCC using intratumoral and peritumoral habitat imaging: multicenter study

Affiliations
Multicenter Study

Preoperative prediction of WHO/ISUP grade of ccRCC using intratumoral and peritumoral habitat imaging: multicenter study

Zhihui Chen et al. Cancer Imaging. .

Abstract

Objectives: The World Health Organization/International Society of Urological Pathology (WHO/ISUP) grading of clear cell renal cell carcinoma (ccRCC) is crucial for prognosis and treatment planning. This study aims to predict the grade using intratumoral and peritumoral subregional CT radiomics analysis for better clinical interventions.

Methods: Data from two hospitals included 513 ccRCC patients, who were divided into training (70%), validation (30%), and an external validation set (testing) of 67 patients. Using ITK-SNAP, two radiologists annotated tumor regions of interest (ROI) and extended surrounding areas by 1 mm, 3 mm, and 5 mm. The K-means clustering algorithm divided the tumor region into three sub-regions, and the Least Absolute Shrinkage and Selection Operator (LASSO) regression identified the most predictive features. Various machine learning models were established, including radiomics models, peritumoral radiomics models, models based on intratumoral heterogeneity (ITH) score, clinical models, and comprehensive models. Predictive ability was evaluated using receiver operating characteristic (ROC) curves, area under the curve (AUC) values, DeLong tests, calibration curves, and decision curves.

Results: The combined model showed strong predictive power with an AUC of 0.852 (95% CI: 0.725-0.979) on the test data, outperforming individual models. The ITH score model was highly precise, with AUCs of 0.891 (95% CI: 0.854-0.927) in training, 0.877 (95% CI: 0.814-0.941) in validation, and 0.847 (95% CI: 0.725-0.969) in testing, proving its superior predictive ability across datasets.

Conclusion: A comprehensive model combining Habitat, Peri1mm, and salient clinical features was significantly more accurate in predicting ccRCC pathologic grading.

Key points: Question: Characterize tumor heterogeneity to non-invasively predict WHO/ISUP pathological grading preoperatively.

Findings: An integrated model combining subregion characterization, peritumoral characteristics, and clinical features can predict ccRCC grade preoperatively.

Clinical relevance: Subregion tumor characterization outperforms the single-entity approach. The integrated model, compared with the radiomics model, boosts grading and prognostic accuracy for more targeted clinical actions.

Keywords: Clear cell renal cell carcinoma; Computed tomography; Habitat analysis; Radiomics; WHO/ISUP grading.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: Institutional Review Board approval was obtained. The study was approved by the Institutional Review Board of the Second Affiliated Hospital of Anhui Medical University [No.YX2024-219]. Written informed consent was waived by the Institutional Review Board. Our study adheres to the"Ethical Review Measures for Life Sciences and Medical Research Involving Humans"(2023), the WMA"Declaration of Helsinki"(2013), the CIOMS"International Ethical Guidelines for Biomedical Research Involving Humans"(2002), and the ethical principles of GCP (Good Clinical Practice). Consent for publication: Consent for publication was obtained from the participants. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Overall workflow of this study. ROI: regions of interest; LASSO: Least Absolute Shrinkage and Selection Operator; MSE: Mean Standard Error; Peri: Peritumoral; DCA: Decision Curves Analysis
Fig. 2
Fig. 2
Presents the Peritumoral and Intratumor Heterogeneity regions generated. Red indicates the intra-tumoral region, and green represents the peritumoral region. The peritumoral region was expanded at intervals of 1 mm, 3 mm, and 5 mm
Fig. 3
Fig. 3
a Presents the Calinski-Harabasz (CH) scores for different numbers of clusters, illustrating the impact of the number of clusters on the segmentation effect for each pattern. b provides a visualization of the DCE features, segmented into three distinct clusters. DCE: Dynamic Contrast-Enhanced
Fig. 4
Fig. 4
a Coefficients of ten-fold cross validation; b MSE of ten-fold cross validation; c The histogram of the Rad-score based on the selected features. MSE: Mean Standard Error
Fig. 5
Fig. 5
Grading prediction results of ccRCC. ROC Curves of Different Models in each cohort (a-c). Different signatures'AUROC on all cohort(d-f). LR: Logistic Regression; AUC: area under the curve; Peri: Peritumoral: ROC: receiver operating characteristic
Fig. 6
Fig. 6
Shows the nomogram for clinical use

Similar articles

References

    1. Li QK, Pavlovich CP, Zhang H, et al. Challenges and opportunities in the proteomic characterization of clear cell renal cell carcinoma (ccRCC): A critical step towards the personalized care of renal cancers. Semin Cancer Biol. 2019;55:8–15. - PMC - PubMed
    1. Schiavoni V, Campagna R, Pozzi V, et al. Recent advances in the management of clear cell renal cell carcinoma: Novel biomarkers and targeted therapies. Cancers. 2023;15(12):3207. - PMC - PubMed
    1. Wang W, Cao KM, Jin SM, et al. Differentiation of renal cell carcinoma subtypes through MRI-based radiomics analysis. Eur Radiol. 2020;30:5738–47. - PubMed
    1. Escudier B, Porta C, Schmidinger M, et al. Renal cell carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2019;30(5):706–20. - PubMed
    1. Ingels A, Campi R, Capitanio U, et al. Complementary roles of surgery and systemic treatment in clear cell renal cell carcinoma. Nat Rev Urol. 2022;19(7):391–418. - PubMed

Publication types